Clinical Trials Logo

Breast Cancer clinical trials

View clinical trials related to Breast Cancer.

Filter by:
  • Enrolling by invitation  
  • Page 1 ·  Next »

NCT ID: NCT03116035 Enrolling by invitation - Breast Cancer Clinical Trials

Impact of Pre-Operative Web-based Breast Cancer Information on the Quality of Patient Decision-Making

Start date: April 24, 2014
Phase: N/A
Study type: Interventional

This is a prospective randomized control trial to compare the impact of two different types of pre-operative web-based breast cancer information on the quality of patient decision making. Patients are emailed web-based information prior to the surgical consultation. Outcomes are assess at multiple time points: 1) prior to the surgical consultation, 2) immediately following the consultation.

NCT ID: NCT03069261 Enrolling by invitation - Breast Cancer Clinical Trials

Intraoperative Indocyanine Green Laser Angiography; Postoperative Outcomes for Autologous Tissue Flaps

Start date: August 1, 2016
Phase: N/A
Study type: Observational

The purpose of this study is to identify and compare complication rates between autologous breast reconstruction techniques with and without the inclusion on intraoperative indocyanine green (ICG) angiography.

NCT ID: NCT02980848 Enrolling by invitation - Breast Cancer Clinical Trials

Assessing Breast Density's Value in Imaging - A Comparative Effectiveness Study

BCSC-ADVANCE
Start date: September 2016
Phase: N/A
Study type: Observational [Patient Registry]

This Beast Cancer Surveillance Consortium (BCSC) ADVANCE study is a large, observational pragmatic comparative effectiveness research study using high-quality, prospectively collected data from BCSC registries to generate evidence on how breast density should be integrated into decision making around breast cancer screening and preoperative diagnostic work-up. We will augment existing BCSC registry infrastructure with additional prospective data collection and collection of patient reported outcomes (PROs), CISNET modeling of long-term screening outcomes, and qualitative data from focus groups with women represented in two aims.

NCT ID: NCT02910986 Enrolling by invitation - Breast Cancer Clinical Trials

Latinas Learning About Density

Start date: September 2016
Phase: N/A
Study type: Interventional

This study will examine behavioral and psychological outcomes of breast density notification using a 3-group randomized design comparing usual written notification to two educationally enhanced approaches.

NCT ID: NCT02897934 Enrolling by invitation - Breast Cancer Clinical Trials

CWI and Discharge After Breast Cancer Surgery

Start date: August 2016
Phase: N/A
Study type: Observational

The objectives of this work are threefold: 1. To evaluate the analgesic efficacy of CWI in women discharged within 23 hours of major breast cancer surgery 2. To evaluate objective indices of patient recovery following anaesthesia and surgery in a 23 hour model of care 3. To evaluate patient satisfaction with their care pathway

NCT ID: NCT02831439 Enrolling by invitation - Breast Cancer Clinical Trials

A Statewide Intervention to Reduce Use of Unproven or Ineffective Breast Cancer Care

Start date: September 2014
Phase: N/A
Study type: Interventional

The goal of this project is to examine the effectiveness and potential cost savings of two organizational interventions aimed at reducing the use of ineffective or unproven care among women with incident breast cancer.

NCT ID: NCT02770586 Enrolling by invitation - Breast Cancer Clinical Trials

Comparison of Positron Emission Mammography and Contrast-enhanced Breast MRI

PEM/MRI
Start date: August 2015
Phase: N/A
Study type: Interventional

The hypothesis of this study is that positron emission mammography will provide comparable sensitivity to contrast-enhanced breast MRI in women with a high suspicion of breast cancer. The aim of this study is to determine the sensitivity of Positron Emission Mammography (PEM) relative to that of Contrast-enhanced breast MRI (CE-MRI) in women with a high suspicion of breast cancer

NCT ID: NCT02765373 Enrolling by invitation - Breast Cancer Clinical Trials

Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients

Start date: January 2015
Phase: N/A
Study type: Observational

This study is a prospective, controlled phase IV clinical trial among postmenopausal patients with hormone receptor-positive breast cancer.The main purpose is to compare the effects of steroidal aromatase inhibitor (AI) exemestane and non-steroidal AIs on the lipid levels of breast cancer patients.

NCT ID: NCT02732860 Enrolling by invitation - Breast Cancer Clinical Trials

Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host

REFLECT
Start date: December 2015
Phase: N/A
Study type: Observational

By obtaining clinical specimens from participants with triple negative breast cancer (TNBC), colorectal cancer (CRC) and other select tumor types to establish and profile as freshly implanted tumors in mice, the aim of this study is to identify agents with predicted activity in the host patient while also potentially providing them with personalized cancer treatment options

NCT ID: NCT02678832 Enrolling by invitation - Breast Cancer Clinical Trials

Momentum Project Heidelberg - Dealing Actively With a Cancerous Disease

Start date: December 2015
Phase: N/A
Study type: Observational

The study, investigates the current physical activity promotion practices among physicians and nurses, as well as social norms toward physical activity during treatment among cancer patients and among physicians and nurses who treat or counsel cancer patients. For this purpose, four large surveys with health care professionals (specialized practitioners, N=300; general practitioners, N=300; oncology nurses, N=300) and cancer patients (N=1200, 400 patients each with breast, prostate or colorectal cancer) with a cross-sectional research design are conducted. Additionally, a follow-up-study with a sub-sample of cancer patients (N=180) will be conducted.